Divalproex Sodium 500 mg DR Tablets (Sandoz Inc., USA)
Sponsors
Sandoz
Conditions
Bipolar DisorderEpilepsy
Phase 1
To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fasting Conditions
CompletedNCT00913874
Start: 2005-10-31End: 2005-10-31Updated: 2017-03-28
To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions
CompletedNCT00913848
Start: 2005-10-31End: 2005-10-31Updated: 2017-03-28